Zimbabwe has turned down a significant US healthcare agreement worth $367m (272 million pounds) spanning five years due to the United States' demand for confidential information.
This rejection was revealed following a official document from December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson has since explained that the United States was seeking genetic material for research and commercial purposes but was not willing to share the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more talks to find a deal agreeable to all parties so the country's vital HIV treatment initiative can continue.
Broader Context
Zimbabwe's decision follows a comparable case in Kenya, where a court blocked a similar health funding agreement following concerns were raised about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
According to reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks already established via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This mechanism is designed to guarantee that when a country contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how subsequent collaboration might be structured in a way that respects the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that negotiations need to persist considering a large portion of the country's Aids initiatives were funded by international support.
"Where technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the ongoing debate between receiving crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.